Get started
Author

Noelia Villarrubia

Observed names: N. Villarrubia, N. Villarrubia Migallón, Noelia Villarrubia Migallón
Observed institutions: University of Basel, Universidad de Alcalá, Instituto de Salud Carlos III, Hospital Universitari Arnau de Vilanova, University Hospital of Basel, Spanish Multiple Sclerosis Network, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario de La Princesa, Comunidad de Madrid, Hospital Universitario de Fuenlabrada, Hospital Universitario Virgen de la Arrixaca, Hospital Universitario Ramón y Cajal, Ministerio de Economía y Competitividad, University of Birmingham
ORCID: 0000-0002-2114-8632
Observed ORCID: 0000-0002-2114-8632
OpenAlex ID: A5063488081
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
2005 · Luisa M. Villar, María C. Sádaba, et al. · Journal of Clinical Investigation · 259
PDF
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
2021 · José I. Fernández-Velasco, Jens Kuhle, et al. · Neurology Neuroimmunology & Neuroinflammation · 67
PDF
Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile
2017 · Silvia Medina, Noelia Villarrubia, et al. · Multiple Sclerosis Journal · 58
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
2024 · Enric Monreal, José Ignacio Fernández-Velasco, et al. · Brain · 50
PDF
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs
2023 · Enric Monreal, José Ignacio Fernández-Velasco, et al. · JAMA Neurology · 50
Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus
2017 · F. J. Carrillo-Salinas, L. Mestre, et al. · Scientific Reports · 45
PDF
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
2021 · Enric Monreal, Susana Sainz de la Maza, et al. · Neurology Neuroimmunology & Neuroinflammation · 40
PDF
Acetate correlates with disability and immune response in multiple sclerosis
2020 · Silvia Pérez-Pérez, María Inmaculada Domínguez-Mozo, et al. · PeerJ · 40
Factors associated with dimethyl fumarate-induced lymphopenia
2019 · Susana Sainz de la Maza, Silvia Medina, et al. · Journal of the Neurological Sciences · 29
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
2021 · Carmen Picón, Amalia Tejeda-Velarde, et al. · Frontiers in Immunology · 28
PDF
Adaptive Features of Natural Killer Cells in Multiple Sclerosis
2019 · Antía Moreira, Elisenda Alari-Pahissa, et al. · Frontiers in Immunology · 27
PDF
Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
2019 · Silvia Medina, Susana Sainz de la Maza, et al. · Annals of Clinical and Translational Neurology · 25
PDF
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults
2024 · Alexander Rodero-Romero, Enric Monreal, et al. · International Journal of Molecular Sciences · 22
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab
2020 · Maria Inmaculada Dominguez-Mozo, Silvia Perez-Perez, et al. · Scientific Reports · 20
Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls
2021 · Maria Inmaculada Dominguez-Mozo, Silvia Perez-Perez, et al. · Cells · 18
PDF
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
2023 · Enric Monreal, José Ignacio Fernández-Velasco, et al. · Frontiers in Immunology · 17
PDF
MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention
2024 · Ainoa Navarrete-Pérez, Sara Gómez-Melero, et al. · International Journal of Molecular Sciences · 15
PDF
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
2022 · Jorge Mena, Iraide Alloza, et al. · Frontiers in Immunology · 15
PDF
Blood lymphocyte subsets identify optimal responders to IFN-beta in MS
2017 · Raquel Alenda, Lucienne Costa-Frossard, et al. · Journal of Neurology · 15
Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis
2025 · Manuel Comabella, Agustín Pappolla, et al. · Neurology Neuroimmunology & Neuroinflammation · 13
PDF
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment
2021 · Paulette Esperanza Walo-Delgado, Susana Sainz de la Maza, et al. · Scientific Reports · 13
PDF
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients
2024 · Raquel Sainz-Amo, Alexander Rodero-Romero, et al. · International Journal of Molecular Sciences · 12
PDF
Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients
2022 · María Inmaculada Domínguez-Mozo, María Celeste García-Frontini Nieto, et al. · Biology · 12
PDF
Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression
2021 · Silvia Pérez-Pérez, María I. Domínguez-Mozo, et al. · Frontiers in Immunology · 12
PDF
Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
2024 · Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, et al. · Frontiers in Immunology · 10
Works count: 59
Citation count: 986
H-index: 16
I10-index: 27
Year
Topic
Type